Author: Giovanni Tosi

Series Title: Frontiers in Nanomedicine

Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects

Volume 2

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2405-9129 (Print)
ISSN: 2405-9137 (Online)
ISBN: 978-1-68108-494-7 (Print)
ISBN: 978-1-68108-493-0 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810849301170201


Frontiers in Nanomedicine offers an up-to-date understanding of nanomaterials to readers having clinical or biomolecular research interests. Scientists, both aspiring and experienced, will find, in each volume, a comprehensive overview of current molecular strategies for using nanoscale materials in medicine.

Nanomedicine and Neurosciences: Advantages, Limitations and Safety Aspects presents different aspects of nanomedicine applied to neuroscience for the diagnosis of disease and the role of nanoparticles in targeted drug delivery systems for neurodegenerative disorders. Topics covered in this volume cover the physiology of neurodegeneration, targeted therapies for Alzheimer’s disease and Parkinson’s disease, blood brain barrier drug delivery systems, in vivo studies of drug nanoconjugates, nanomedicine safety, and more.


- Pp. i
Frank Boury, Philippe Menei
Download Free


- Pp. II
Giovanni Tosi
Download Free

List of Contributors

- Pp. III
Giovanni Tosi
Download Free

Nanomedicine and Neurodegenerative Diseases: An Introduction to Pathology and Drug Targets

- Pp. 1-60 (60)
Tasnuva Sarowar, Andreas M. Grabrucker
View Abstract

Nanoparticles Targeting Mitochondria in Neurodegenerative Diseases: Toxicity and Challenge for Nanotherapeutics

- Pp. 61-100 (40)
Michal Cagalinec
View Abstract

Neuronal Mechanisms for Nanotopography Sensing

- Pp. 101-114 (14)
Ilaria Tonazzini, Marco Cecchini
View Abstract

Drug Delivery to the Brain by Liposomal Carrier Systems

- Pp. 115-127 (13)
Anne Mahringer, Gert Fricker
View Abstract

Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology

- Pp. 128-155 (28)
Cinzia M. Bellettato, David J. Begley, Christina Lampe, Maurizio Scarpa
View Abstract

Targeting Brain Disease in Mucopolysaccharidoses

- Pp. 156-183 (28)
Marika Salvalaio, Laura Rigon, Francesca D’Avanzo, Elisa Legnini, Valeria Balmaceda Valdez, Alessandra Zanetti, Rosella Tomanin
View Abstract

Functional Validation of Drug Nanoconjugates in vivo

- Pp. 184-198 (15)
Ibane Abasolo, Yolanda Fernández, Simó Schwartz
View Abstract

How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art

- Pp. 199-238 (40)
F. Pederzoli, M. Galliani, F. Forni, M .A. Vandelli, D. Belletti, G. Tosi, B. Ruozi
View Abstract

Safety of Nanomedicine: Neuroendocrine Disrupting Potential of Nanoparticles and Neurodegeneration

- Pp. 239-262 (24)
Eva Rollerova, Alzbeta Bujnakova Mlynarcikova, Jana Tulinska, Jevgenij Kovriznych, Alexander Kiss, Sona Scsukova
View Abstract

Subject Index

- Pp. 263-269 (7)
Giovanni Tosi
Download Free


.Role of Nanotechnology in Cancer Therapy.
.Nanomaterials for Environmental Applications and their Fascinating Attributes.
.Introduction to Carbon Nanomaterials.
.Frontiers in Nanomedicine.